| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/02/2000 | EP1024189A1 Novel antigenic class of avian reoviruses |
| 08/02/2000 | EP1023467A1 Method for measuring viral infectivity |
| 08/02/2000 | EP1023452A1 Gene delivery vectors and their uses |
| 08/02/2000 | EP1023451A1 Methods of replicating virus in monocyte-derived macrophage cultures |
| 08/02/2000 | CN1261873A Methods and compositions for selective modification of nucleic acids |
| 08/02/2000 | CA2297507A1 Synthetic gene of bovine viral diarrhoea virus |
| 08/01/2000 | US6096534 Nucleic acid of long terminal repeat from virus, of gag and pol regions of virus, and from viral envelope region; vectors which replicate efficiently in avian cells and replication-defective in mammalian cells; gene therapy and vaccines |
| 08/01/2000 | US6096304 Neurotoxins coding nucleotide sequences for gene expression |
| 08/01/2000 | CA2201601C Chimeric papillomavirus-like particles |
| 07/27/2000 | WO2000043549A1 Lipophilic quenching of viral inactivating agents |
| 07/27/2000 | WO2000023574A3 Hepatitis a vaccines |
| 07/27/2000 | WO2000012684A3 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus |
| 07/27/2000 | WO2000009699A9 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 07/27/2000 | CA2360803A1 Lipophilic quenching of viral inactivating agents |
| 07/26/2000 | EP1022338A2 Viral vaccines |
| 07/26/2000 | EP1021553A2 Eukaryotic gene expression cassette and uses thereof |
| 07/26/2000 | EP1021547A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 07/26/2000 | EP1021544A2 Chimeric vaccine against tick-borne encephalitis virus |
| 07/26/2000 | EP1021526A1 GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV |
| 07/26/2000 | EP1021524A1 Chromatographically concentrated baculovirus and methods |
| 07/26/2000 | EP0629135B1 Viral inactivation method |
| 07/26/2000 | CN1261404A Lentivirus-Based gene transfer vectors. |
| 07/25/2000 | US6093570 Cotransfecting cells permissive for adenovirus-associated virus replication with a recombinant adeno-associated virus vector, a helper adeno-associated virus vector and a helper virus vector to produce infectious virions and collecting |
| 07/25/2000 | US6093564 Methods and compositions for the selective modification of nucleic acids |
| 07/25/2000 | US6093550 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 07/25/2000 | US6093544 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses |
| 07/25/2000 | US6093405 Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines |
| 07/25/2000 | US6093392 Comprising a recombinant adeno-associated viral vector |
| 07/25/2000 | CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 07/20/2000 | WO2000042561A2 Oligonucleotide mediated nucleic acid recombination |
| 07/20/2000 | WO2000042560A2 Methods for making character strings, polynucleotides and polypeptides |
| 07/20/2000 | WO2000042432A1 Purification process using magnetic particles |
| 07/20/2000 | WO2000042208A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 07/20/2000 | WO2000042068A2 Hiv related peptides |
| 07/20/2000 | WO2000042050A1 Sulfated phosphatidylinositols, their preparation and use |
| 07/20/2000 | WO2000020573A3 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| 07/20/2000 | WO2000020041A3 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 07/20/2000 | CA2359795A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 07/20/2000 | CA2320714A1 Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| 07/20/2000 | CA2320697A1 Oligonucleotide mediated nucleic acid recombination |
| 07/19/2000 | EP1019510A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 07/19/2000 | EP1019508A1 Tnf-related death ligand |
| 07/19/2000 | EP1019083A1 Methods and compositions for the selective modification of nucleic acids |
| 07/19/2000 | EP1018863A1 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 07/19/2000 | CN1054544C Polypeptide vaccine for mouth and hoof disease of domestic animal and preparation method |
| 07/18/2000 | US6090608 Viral expression vector coding heterologous proteins; for the treatment of thalassemia, hemopoietic defects, bacterial and viral infctions, atherosclerosis, autoimmune diseases or allergies; anticarcinogenic agents |
| 07/18/2000 | US6090588 Simple and inexpensive process to produce large amounts by inoculating bacteria with inactivated virus, allowing virus to be incorporated into bacteria, contacting with amino acid source to initiate production of pyomelanin and recovering |
| 07/18/2000 | US6090391 Recombinant tryptophan mutants of influenza |
| 07/18/2000 | CA2108777C Modified plant viruses as vectors |
| 07/18/2000 | CA1341055C Transfectant cell lines which express the major human rhinovirus receptor |
| 07/13/2000 | WO2000040734A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 07/13/2000 | WO2000040702A1 Method for separating viral particles |
| 07/13/2000 | WO2000040602A1 Binding molecules for human factor viii and factor viii-like proteins |
| 07/13/2000 | WO2000002524A9 Botulinum neurotoxin vaccine |
| 07/13/2000 | WO1997020575A8 Targeted adenovirus vectors |
| 07/13/2000 | CA2356937A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 07/13/2000 | CA2356373A1 Method for separating viral particles |
| 07/13/2000 | CA2354599A1 Binding molecules for human factor viii and factor viii-like proteins |
| 07/12/2000 | EP1018557A2 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 07/12/2000 | EP1018556A1 Chimeric and/or growth-restricted flaviviruses |
| 07/12/2000 | EP1018555A2 Chimeric papilomavirus-like particles |
| 07/12/2000 | EP1017838A2 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 07/12/2000 | EP1017837A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 07/12/2000 | EP1017807A1 Osf2/cbfa1 compositions and methods of use |
| 07/12/2000 | EP1017797A1 Non-primate lentiviral vectors and packaging systems |
| 07/12/2000 | EP1017791A1 Recombinant rsv virus expression systems and vaccines |
| 07/12/2000 | EP1017407A2 Useful properties of human lactoferrin and variants thereof |
| 07/12/2000 | EP0550553B1 Viral defective vaccine produced by transcomplementing cell line |
| 07/12/2000 | CN1259670A Method and reagent used for detecting virus of hepatitis C |
| 07/11/2000 | US6087170 VZV gene, mutant VZV and immunogenic compositions |
| 07/11/2000 | US6087141 Inactivation of intracellular or extracellular virus within a biocompatible sample; insertion of sample into radiation sensitizer and exposure to ultraviolet radiation or incubate sample with solvent, a detergent or heat treat |
| 07/11/2000 | US6087127 Nucleotide sequence which codes a viral disease polypeptide; for the development of vaccines for prevention of viral infection |
| 07/11/2000 | US6087110 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| 07/11/2000 | US6086895 Treatment with proteins and polypeptides |
| 07/11/2000 | US6086892 Poultry vaccine |
| 07/11/2000 | US6086891 Plasmids |
| 07/11/2000 | US6086890 Bovine adenovirus expression vector system |
| 07/06/2000 | WO2000039304A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | WO2000039303A2 Modified hiv env polypeptides |
| 07/06/2000 | WO2000039302A2 Improved expression of hiv polypeptides and production of virus-like particles |
| 07/06/2000 | WO2000039151A1 Neutralizing assay using human papillomavirus virus-like particles |
| 07/06/2000 | WO2000000616A3 Marburg virus vaccines |
| 07/06/2000 | CA2719413A1 Compositions and methods for packaging of alphavirus vectors |
| 07/06/2000 | CA2358385A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | CA2355883A1 Neutralizing assay using human papillomavirus virus-like particles |
| 07/05/2000 | EP1016711A1 Process for inactivating enveloped viruses in a viral preparation containing non-enveloped viruses |
| 07/05/2000 | EP1016418A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/05/2000 | EP1015826A2 Long-term shelf preservation by vitrification |
| 07/05/2000 | EP1015620A1 Plasmids for construction of eukaryotic viral vectors |
| 07/05/2000 | EP1015619A1 Methods and cell line useful for production of recombinant adeno-associated viruses |
| 07/05/2000 | EP1015594A1 Attenuated respiratory syncytial viruses |
| 07/05/2000 | EP1015561A1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps) |
| 07/05/2000 | EP1015560A1 Modified small rna viruses |
| 07/05/2000 | EP1015559A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use |
| 07/05/2000 | EP1015009A1 Attenuated vif dna immunization cassettes for genetic vaccines |
| 07/05/2000 | CN1259171A Retroviral vector particles produced in a baculovirus expression system |
| 07/05/2000 | CN1259051A Stabilized human papillomavirus formulations |
| 07/05/2000 | CN1258742A Recombined toxin adenovirus mutant for treating tumor caused by tumor suppressor p53 defect |
| 07/05/2000 | CN1258741A Recombined Chinese bollworm virus |
| 07/05/2000 | CN1258740A Recombined adhenovirus expressing human interleukin 12 and its preparation and use |